MTMP Las Vegas · Bellagio · Oct 13–15  Book a meeting with Jacob →

Tort · Mass Tort Glossary

AFFF (Aqueous Film-Forming Foam) Tort — Mass Tort Marketing Campaign

Also known as: Firefighter Foam

Firefighting foam used extensively by military installations and airports since the 1960s, found to contain PFAS compounds linked to cancer. AFFF litigation is one of the largest active mass tort dockets, with tens of thousands of cases consolidated in federal MDL. Strong entry window for military veterans and airport workers with qualifying diagnoses.

Related terms

Run this in a real campaign

Mass Tort Ad Agency manages claimant-acquisition campaigns built on the concepts in this glossary — transparent cost-plus-15% pricing, in-house CloudIntake qualification, and chain-of-custody on every signed retainer. See the torts we run or book a strategy call.

The language of mass tort advertising

This glossary is compiled by Mass Tort Ad Agency from 15 years and $250M+ in plaintiff Meta ad spend. Browse the full reference or talk to our team.

Browse the full glossary

Who an AFFF campaign targets

An AFFF claimant-acquisition campaign focuses on military veterans, active-duty personnel, and career or volunteer firefighters who used aqueous film-forming foam during service or training, and who have since been diagnosed with a PFAS-linked condition: kidney cancer, bladder cancer, testicular cancer, or thyroid disease.

Because AFFF was deployed at military bases and fire training facilities across every U.S. media market, the exposed population is geographically broad and identifiable through occupational and service records — making precise paid-social targeting practical before a single dollar is spent on creative testing.

What qualifying diagnoses does an AFFF mass tort campaign target?

Campaigns focus on claimants diagnosed with kidney cancer, bladder cancer, testicular cancer, or thyroid disease following occupational exposure to AFFF at military bases, fire departments, or airports.

Is AFFF intake currently open?

Yes. Intake is currently open and the litigation is consolidated in an MDL, so firms acquiring claimants now are building inventory in an active, organized proceeding.